| 0 (0%) | 12-26 20:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.27 |
1-year : | 3.81 |
| Resists | First : | 2.79 |
Second : | 3.27 |
| Pivot price | 2.48 |
|||
| Supports | First : | 2.37 |
Second : | 2.1 |
| MAs | MA(5) : | 2.52 |
MA(20) : | 2.44 |
| MA(100) : | 2.76  |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 76.5 |
D(3) : | 57.5 |
| RSI | RSI(14): 62.5 |
|||
| 52-week | High : | 10.15 | Low : | 2.1 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ BMRA ] has closed below upper band by 5.4%. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.8 - 2.81 | 2.81 - 2.82 |
| Low: | 2.57 - 2.59 | 2.59 - 2.6 |
| Close: | 2.68 - 2.7 | 2.7 - 2.71 |
Tue, 23 Dec 2025
Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade
Tue, 23 Dec 2025
Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com
Tue, 23 Dec 2025
Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative
Tue, 23 Dec 2025
Medicare sets $300 price for new food-trigger test to ease IBS pain - Stock Titan
Sat, 20 Dec 2025
Forecast Cut: Can BMRA stock outperform in 2025 bull market - July 2025 Technicals & Safe Capital Allocation Plans - moha.gov.vn
Thu, 18 Dec 2025
How BMRA stock performs in rate cut cycles - Quarterly Earnings Summary & Reliable Entry Point Trade Alerts - Улправда
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 3 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 10.3 (%) |
| Held by Institutions | 3 (%) |
| Shares Short | 30 (K) |
| Shares Short P.Month | 35 (K) |
| EPS | -1.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.83 |
| Profit Margin | -74.9 % |
| Operating Margin | -81.1 % |
| Return on Assets (ttm) | -41.5 % |
| Return on Equity (ttm) | -69.7 % |
| Qtrly Rev. Growth | -23.7 % |
| Gross Profit (p.s.) | 0.21 |
| Sales Per Share | 1.65 |
| EBITDA (p.s.) | -1.63 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -1.77 |
| PEG Ratio | 0 |
| Price to Book value | 1.47 |
| Price to Sales | 1.63 |
| Price to Cash Flow | -2.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|